New research reveals that patients who come off blockbuster slimming jabs like Wegovy and Mounjaro can put back on reduced body mass much more quickly than those who end traditional diet and exercise plans.
Findings released in a leading health publication demonstrates that while obese people often shed about a fifth of their body weight while undergoing treatment, the mass returns at an average rate of 0.8 kg per month once they quit.
"Users buying these medications should be cognizant of the risk of rapid weight regain when the medication concludes," warns lead investigator Dr. Susan Jebb.
This pace of recovery implies a return to starting weight in about one and a half years.
Weighing Treatments
The study, which examined dozens of trials involving thousands of participants, compared the results of these new drugs with conventional dieting.
Researchers emphasize that people who lose weight through dieting usually see a slower weight regain—approximately 0.1 kg a month—post-intervention.
The Reason for the Rapid Regain
Doctors propose the mechanism of the jabs is key to understanding the accelerated weight return.
These medications imitate a body's own chemical called glucagon-like peptide-1, which controls feelings of fullness.
"Long-term administration of GLP-1 levels far above than the body's typical production could lead to the system to generate a reduced amount of its own natural hormone, and may also reduce sensitivity to its actions," noted Dr. Adam Collins, a dietetics expert.
"Discontinuation of this GLP-1 'fix' leads to appetite is unsuppressed, making overeating much more probable."
A Lifelong Condition?
Medical guidelines advise the jabs for individuals with weight-linked medical conditions, accompanied by prescribed lifestyle changes.
Many experts contend that, due to the likelihood of relapse, the treatment might need to be long-term.
This opinion is supported by drug manufacturers, who say that the results "underscore the long-term nature of obesity," similar to managing diseases like hypertension.
User Accounts
Users who have stopped the jabs report a sudden resurgence of appetite.
"I experienced something flipping and I was suddenly ravenous," said a patient.
The struggle is exacerbated if individuals have not established permanent lifestyle or habit changes during treatment.
Significant Interest
Recent estimates show that a significant number of adults in the UK have used these injections in the last 12 months, with desire continuing to grow.
- Adoption is higher among women than men.
- The middle-aged age group shows the greatest usage rates.
- A large proportion obtain the drugs through private prescriptions rather than the NHS.
In conclusion, experts emphasize that while the jabs are potent tools for shedding pounds, they are not a magic solution and maintained weight loss hinges on integrated behavioural support.
